Science and Technology Part 4: Genome India, Biotech Startups and the Bio-E3 Push, Exam-Ready Notes

1 min read · 79 words
Civil ExamsCivil Services1 min read

Bio-economy is the rare sector where the syllabus and the budget agree.

Genome India

  • 10,000 Indian genomes sequenced, dataset completed 2025; fuel for population-scale medicine.

Bio-E3 policy 2024

  • Bio-economy for economy, employment and exports; roughly $130 bn in 2024, $300 bn goal by 2030.
  • Bio-enabling parks, biofoundries and bio-AI thrust areas.

Delivery proof-points

  • NexCAR19: indigenous CAR-T therapy approved 2023 at a fraction of US cost.
  • 6,000+ biotech startups; vaccine platform capacity from the COVID years.

Revise in 30 seconds

  • Genome India: 10,000 genomes, 2025.
  • Bio-E3: $300 bn bio-economy by 2030.
  • NexCAR19: indigenous CAR-T, 2023.

Quick revision

  • 10,000 Indian genomes sequenced, dataset completed 2025; fuel for population-scale medicine.
  • Bio-economy for economy, employment and exports; roughly $130 bn in 2024, $300 bn goal by 2030.
  • Bio-enabling parks, biofoundries and bio-AI thrust areas.
  • NexCAR19: indigenous CAR-T therapy approved 2023 at a fraction of US cost.
  • 6,000+ biotech startups; vaccine platform capacity from the COVID years.
  • Genome India: 10,000 genomes, 2025.